The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.

The lawsuit accuses pharmaceutical companies of “deceptively marketing” Tylenol as a safe option for pregnant mothers.

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a common pain reliever is linked to autism.

Texas Attorney General Ken Paxton is suing Johnson and Johnson, accusing the pharmaceutical company of failing to warn consumers about the risk of taking Tylenol while pregnant. This lawsuit, the first of its kind from a state government,

President Trump's health secretary said Tylenol should be used with caution during pregnancy, but solid data linking it to autism is lacking.

Kimberly-Clark, the maker of Huggies, is set to acquire Kenvue, the parent company of Tylenol, in a nearly $50 billion deal.